←Back to Expert Scholars
Translational Medicine / 转化医学Ovarian Cancer, Rucaparib ARIEL
Robert L Coleman
MD
🏢US Oncology Research🌐USA
Chief Scientific Officer
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Robert Coleman led the ARIEL3 trial of rucaparib maintenance in ovarian cancer and contributed to VELIA defining veliparib addition to chemotherapy. He has authored hundreds of gynecologic oncology clinical trial publications. He currently leads clinical research strategy at US Oncology.
Share:
🧪Research Fields 研究领域
ARIEL3 rucaparib
maintenance PARP
veliparib VELIA
platinum resistance
gynecologic clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Robert L Coleman 的研究动态
Follow Robert L Coleman's research updates
留下邮箱，当我们发布与 Robert L Coleman（US Oncology Research）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment